188 related articles for article (PubMed ID: 23957982)
21. Carbamazepine-induced Stevens-Johnson syndrome treated with IV steroids and IVIG.
Straussberg R; Harel L; Ben-Amitai D; Cohen D; Amir J
Pediatr Neurol; 2000 Mar; 22(3):231-3. PubMed ID: 10734256
[TBL] [Abstract][Full Text] [Related]
22. Use of granulocyte colony-stimulating factor in the treatment of toxic epidermal necrolysis--experience with 3 patients.
Mahajan R; Kanwar AJ
Skinmed; 2013; 11(5):269-71. PubMed ID: 24340465
[TBL] [Abstract][Full Text] [Related]
23. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
24. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
26. [Use of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis and Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Review of 15 cases].
Molgó M; Carreño N; Hoyos-Bachiloglu R; Andresen M; González S
Rev Med Chil; 2009 Mar; 137(3):383-9. PubMed ID: 19621180
[TBL] [Abstract][Full Text] [Related]
27. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy".
Sherertz EF; Jegasothy BV; Lazarus GS
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 2):178-81. PubMed ID: 3973116
[TBL] [Abstract][Full Text] [Related]
28. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
29. Acute management of Stevens-Johnson syndrome and toxic epidermal necrolysis to minimize ocular sequelae.
Tseng SC
Am J Ophthalmol; 2009 Jun; 147(6):949-51. PubMed ID: 19463535
[No Abstract] [Full Text] [Related]
30. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
31. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
32. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
Watanabe H; Iijima M
Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
[No Abstract] [Full Text] [Related]
33. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
34. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
[TBL] [Abstract][Full Text] [Related]
35. Stevens-Johnson syndrome with idiopathic thrombocytopenic purpura treated with dexamethasone pulse therapy.
Barman KD; Verma KK; Agrawal S; Agarwalla A; Rijal A
J Dermatol; 2003 Jan; 30(1):54-8. PubMed ID: 12598710
[TBL] [Abstract][Full Text] [Related]
36. Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report.
Demiral AN; Yerebakan O; Simşir V; Alpsoy E
Jpn J Clin Oncol; 2002 Nov; 32(11):477-9. PubMed ID: 12499421
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
39. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.
Dumas M; Hua C; Hotz C; Velter C; Duong TA; Maraffi T; Ortonne N; Hüe S; Fardet L; de Prost N; Wolkenstein P; Ingen-Housz-Oro S; Chosidow O
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e360-e361. PubMed ID: 29524279
[No Abstract] [Full Text] [Related]
40. [Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease].
Kohut M; Hartleb M; Hartleb T
Pol Merkur Lekarski; 2010 Sep; 29(171):169-72. PubMed ID: 20931826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
